Literature DB >> 6682993

Effect of hormones on urethral sensitivity to phenylephrine in normal and incontinent dogs.

K E Creed.   

Abstract

The effects of stilboestrol and progesterone on pressure responses of the urethra to the alpha-adrenergic agonist, phenylephrine, were investigated in normal and incontinent ovariectomised dogs. It was found that progesterone had no significant effect on normal dogs but after pretreatment with stilboestrol the dose response curve was shifted to the left so that one third to one eighth of the original dose of phenylephrine produced the same response. In incontinent animals the sensitivity to phenylephrine was reduced compared with normal animals and stilboestrol either had no effect or only partially restored normal sensitivity. These results suggest that incontinence may result in part from decreased effectiveness of adrenergic innervation to the urethra.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6682993

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  4 in total

1.  Urinary incontinence after spaying in the bitch: incidence and oestrogen-therapy.

Authors:  A Angioletti; I De Francesco; M Vergottini; M L Battocchio
Journal:  Vet Res Commun       Date:  2004-08       Impact factor: 2.459

Review 2.  Estrogen therapy and urinary incontinence: what is the evidence and what do we tell our patients?

Authors:  L Elaine Waetjen; Peter L Dwyer
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-03-15

3.  The effects of oestrogens on spontaneous activity and responses to phenylephrine of the mammalian urethra.

Authors:  S M Callahan; K E Creed
Journal:  J Physiol       Date:  1985-01       Impact factor: 5.182

4.  Urodynamic investigation by telemetry in Beagle dogs: validation and effects of oral administration of current urological drugs: a pilot study.

Authors:  Stéphanie Noël; Laurent Massart; Annick Hamaide
Journal:  BMC Vet Res       Date:  2013-10-08       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.